Amid a new wave of infections, what should the world expect next year?
The Economist todayeradicated
. Only one disease, smallpox, has ever been eliminated. Instead, global immunity will increase as more people are vaccinated or contract covid-19. Some 3.8bn have had at least one jab and 2.8bn are fully vaccinated. Together with those who have caught the disease, around half the world’s population has some level of immunity. Eventually, covid-19 will become endemic: transmission will remain at a steady rate, following seasonal patterns, with fewer spikes in infection.
In the meantime, vaccines and treatments will continue to lower the burden of the disease. By the second half of 2022 there will probably be a
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Here's How Many Daily COVID-19 Cases Might Get Us Back to ‘Normal,’ Per Dr. FauciPlus, how we make it happen.
続きを読む »
Moderna seeks U.S. authorization of COVID-19 booster shots for all adultsModerna Inc said on Wednesday it had applied with the U.S. Food and Drug Administration for authorization of its COVID-19 booster vaccine for all adults aged 18 and older.
続きを読む »
Eating disorder hospitalizations doubled during COVID-19 pandemic, new data showsThe number of people who were hospitalized for eating disorders in the U.S. doubled during the COVID-19 pandemic, new research shows.
続きを読む »
U.S. looking to broaden access to COVID-19 antiviral pills - WSJThe administration is reviewing whether Paxlovid, the antiviral from Pfizer Inc, can be available on the commercial market in retail pharmacies if it gets regulatory clearance, the Journal reported. Molnupiravir, an oral pill from Merck & Co Inc and Ridgeback Biotherapeutics LP that is also under regulatory review, may be included in the government's plan to make it commercially available, the journal reported, citing the person. The United States has agreed to buy 10 million courses of Pfizer's drug and has so far secured 3.1 million courses of Merck's pill.
続きを読む »
Everything you need to know about getting a COVID-19 boosterMixing and matching is approved, and all adults are currently eligible for booster shots.
続きを読む »
All U.S. Adults Can Now Get a COVID-19 Booster Shotthe FDA approved booster shots for everyone 18 and older who received their second dose of the Pfizer or Moderna vaccine at least six months ago.
続きを読む »